Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MKL
MKL logo

MKL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Markel Group Inc (MKL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1965.840
1 Day change
0.08%
52 Week Range
2207.590
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Markel Group Inc (MKL) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in its latest quarter, the absence of immediate positive trading signals, neutral trading sentiment, and lack of significant news catalysts suggest that it is better to hold off on investing right now. The stock may still perform well over the long term, but there are no clear indicators of an optimal entry point currently.

Technical Analysis

The MACD is positive at 13.316, indicating bullish momentum, but it is contracting. RSI is neutral at 62.512, and moving averages are converging, showing no strong trend. The stock is trading near a resistance level (R1: 1984.894), which could limit short-term upward movement.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
5

Positive Catalysts

  • Strong financial performance in Q4 2025, with revenue up 7.64% YoY, net income up 21.05% YoY, and EPS up 25.80% YoY. Analysts have a long-term positive outlook on the stock.

Neutral/Negative Catalysts

  • No recent news or significant trading trends. Analysts are cautious about short-term performance due to management changes. No recent trading activity from Congress or influential figures.

Financial Performance

In Q4 2025, revenue increased to $4.02 billion (up 7.64% YoY), net income increased to $606.16 million (up 21.05% YoY), and EPS increased to 48.76 (up 25.80% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Brean Capital resumed coverage with a Neutral rating and a $2,100 price target, citing uncertainty in short-term performance. Truist raised the price target to $2,100 but maintained a Hold rating.

Wall Street analysts forecast MKL stock price to rise
Analyst Rating
0
Wall Street analysts forecast MKL stock price to rise
Buy
Hold
Sell
0
Current: 1964.290
sliders
Low
0
Averages
0
High
0
0
Current: 1964.290
sliders
Low
0
Averages
0
High
0
Brean Capital
Neutral
maintain
$2,100
AI Analysis
2026-03-24
Reason
Brean Capital
Price Target
$2,100
AI Analysis
2026-03-24
maintain
Neutral
Reason
Brean Capital resumed coverage of Markel with a Neutral rating and $2,100 price target. The firm believes shares will outperform the S&P 500 over time, but performance in the next 12 months is "less certain" given the numerous changes management has made to shore up profitability in Markel Insurance, the analyst tells investors.
Truist
Mark Hughes
Hold
maintain
2026-02-06
Reason
Truist
Mark Hughes
Price Target
2026-02-06
maintain
Hold
Reason
Truist analyst Mark Hughes raised the firm's price target on Markel to $2,100 from $2,000 and keeps a Hold rating on the shares after its Q4 results. The company appears to be executing well based on its sharpened focus within Markel Insurance along with tailwinds in the Financial operation, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MKL
Unlock Now

People Also Watch